Raymond James & Associates’s Medallia, Inc. MDLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-221,081
Closed -$7.46M 4317
2021
Q2
$7.46M Buy
221,081
+67,125
+44% +$1.93M 0.01% 1235
2021
Q1
$4.29M Buy
153,956
+48,841
+46% +$1.81M ﹤0.01% 1517
2020
Q4
$3.49M Sell
105,115
-68,782
-40% -$2.19M ﹤0.01% 1542
2020
Q3
$4.77M Buy
173,897
+161,063
+1,255% +$4.89M 0.01% 1255
2020
Q2
$324K Sell
12,834
-1,682
-12% -$40.2K ﹤0.01% 2874
2020
Q1
$291K Buy
+14,516
New +$390K ﹤0.01% 2797

Other funds holding MDLA

Raymond James & Associates's MDLA Position: Q3 2021 in Review

Raymond James & Associates sold out of Medallia, Inc. (MDLA) in Q3 2021, closing a stake of 221,081 shares — an estimated $7.46M sold.

Raymond James & Associates first reported a position in MDLA in Q1 2020 and held it in 6 quarters. The position peaked at $7.46M in Q2 2021. 208 funds tracked by Wall St. Rank hold MDLA as of Q3 2021.

  • Raymond James & Associates reported no remaining Medallia, Inc. position as of Q3 2021 after selling out during the quarter.
  • Raymond James & Associates sold 221,081 Medallia, Inc. shares in Q3 2021, an estimated $7.46M.
  • Raymond James & Associates first reported a position in Medallia, Inc. in Q1 2020 and held it in 6 quarters.
  • Raymond James & Associates's Medallia, Inc. position peaked at $7.46M in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Medallia, Inc. as of Q3 2021.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.